Mersana Therapeutics Inc (MRSN)
1.91
+0.07
(+3.80%)
USD |
NASDAQ |
Nov 05, 10:29
Mersana Therapeutics Price to Book Value: 27.80 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 26.79 |
| November 01, 2024 | 26.49 |
| October 31, 2024 | 26.35 |
| October 30, 2024 | 27.22 |
| October 29, 2024 | 28.24 |
| October 28, 2024 | 29.70 |
| October 25, 2024 | 27.66 |
| October 24, 2024 | 29.26 |
| October 23, 2024 | 29.99 |
| October 22, 2024 | 29.84 |
| October 21, 2024 | 30.57 |
| October 18, 2024 | 30.57 |
| October 17, 2024 | 30.72 |
| October 16, 2024 | 30.72 |
| October 15, 2024 | 31.01 |
| October 14, 2024 | 29.99 |
| October 11, 2024 | 28.68 |
| October 10, 2024 | 27.66 |
| October 09, 2024 | 27.37 |
| October 08, 2024 | 28.97 |
| October 07, 2024 | 28.53 |
| October 04, 2024 | 30.86 |
| October 03, 2024 | 29.41 |
| October 02, 2024 | 29.70 |
| October 01, 2024 | 26.64 |
| Date | Value |
|---|---|
| September 30, 2024 | 27.51 |
| September 27, 2024 | 26.93 |
| September 26, 2024 | 26.93 |
| September 25, 2024 | 26.20 |
| September 24, 2024 | 27.44 |
| September 23, 2024 | 28.31 |
| September 20, 2024 | 31.44 |
| September 19, 2024 | 31.88 |
| September 18, 2024 | 30.86 |
| September 17, 2024 | 29.70 |
| September 16, 2024 | 28.68 |
| September 13, 2024 | 30.72 |
| September 12, 2024 | 25.77 |
| September 11, 2024 | 25.77 |
| September 10, 2024 | 23.00 |
| September 09, 2024 | 21.84 |
| September 06, 2024 | 19.65 |
| September 05, 2024 | 20.67 |
| September 04, 2024 | 20.96 |
| September 03, 2024 | 21.11 |
| August 30, 2024 | 23.00 |
| August 29, 2024 | 22.13 |
| August 28, 2024 | 21.69 |
| August 27, 2024 | 22.71 |
| August 26, 2024 | 23.73 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9521
Minimum
Nov 05 2019
32.75
Maximum
Jul 16 2024
7.634
Average
5.249
Median
Oct 07 2020
Price to Book Value Benchmarks
| Chimerix Inc | 0.5762 |
| Cellectar Biosciences Inc | 18.28 |
| Marinus Pharmaceuticals Inc | -- |
| Jaguar Health Inc | 0.5630 |
| Seres Therapeutics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 7.737 |
| Price | 1.91 |
| Earnings Yield | -45.55% |
| Market Cap | 234.31M |